Covid Vaccine Makers Kept Prepayments for Canceled Shots for Poor Nationsnews2023-02-01T17:44:17+00:00February 1st, 2023|The New York Times|
The Only H.I.V. Vaccine in Advanced Trials Has Failed. What Now?news2023-01-18T21:26:06+00:00January 18th, 2023|The New York Times|
Johnson & Johnson Will Discontinue Talc-Based Baby Powder Globally in 2023news2022-08-12T02:53:50+00:00August 12th, 2022|The New York Times|
McKinsey Guided Companies at the Center of the Opioid Crisisnews2022-06-29T23:24:22+00:00June 29th, 2022|The New York Times|
Fuad El-Hibri, Who Led a Troubled Vaccine Maker, Dies at 64news2022-04-30T19:09:09+00:00April 30th, 2022|The New York Times|
Lawmakers Dismiss McKinsey’s Apology on Opioid Crisis as ‘Empty’news2022-04-27T22:34:40+00:00April 27th, 2022|The New York Times|
F.D.A. Allows Second Coronavirus Boosters for Everyone 50 and Oldernews2022-03-29T23:44:53+00:00March 29th, 2022|The New York Times|
Companies Finalize $26 Billion Deal With States and Cities to End Opioid Lawsuitsnews2022-02-25T14:12:55+00:00February 25th, 2022|The New York Times|
J.&J. Pauses Production of Its Covid Vaccine Despite Persistent Neednews2022-02-08T16:04:03+00:00February 8th, 2022|The New York Times|
Tribes Reach $590 Million Opioid Settlement With Johnson & Johnsonnews2022-02-01T22:52:05+00:00February 1st, 2022|The New York Times|
